1,079
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Homocysteine effects on cellular glutathione peroxidase (GPx-1) activity under in vitro conditions

&
Pages 733-738 | Received 07 Sep 2006, Accepted 16 Nov 2006, Published online: 04 Oct 2008

References

  • Apostolova MD, Bontchev PR, Ivanova BB, et al. Copper-homocysteine complexes and potential physiological actions. J Inorg Biochem 2003; 95: 321–333
  • Still RA, McDowell IF. Clinical implications of plasma homocysteine measurement in cardiovascular disease. J Clin Pathol 1998; 51: 183–188
  • Pastore A, Massoud R, Motti C, et al. Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine. Clin Chem 1998; 44: 825–832
  • Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354: 407–413
  • Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. The metabolic and molecular bases of inherited disease8th, CR Scriver, AL Beaudet, WS Sly, D Valle. McGraw-Hill Companies, New York 2001; 2007–2043
  • Refsum H, Fiskerstrand T, Guttormsen AB, Ueland PM. Assessment of homocysteine status. J Inher Metab Dis 1997; 20: 286–294
  • Nygard O, Vollset SE, Refsum H, Brattström L, Ueland PM. Total homocysteine and cardiovascular disease. J Intern Med 1999; 246: 425–454
  • Ragone R. Homocystine solubility and vascular disease. FASEB J 2002; 16(401)4
  • Monsen AL, Ueland PM. Homocysteine and methylmalonic acid in diagnosis and risk assesement from infancy to adolescence. Am J Clin Nutr 2003; 78: 7–21
  • Romerio SC, Linder L, Nyfeler J, et al. Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults. Atherosclerosis 2004; 176(337)44
  • Miller JW. Homocysteine and alzheimer's Disease. Nutr Rev 1999; 57: 126–129
  • Ho PI, Collins SC, Dhitavat S, et al. Homocysteine potentiates β-amyloid neurotoxicity: Role of oxidative stress. J Neurochem 2001; 78(1)6
  • Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Tamura T. Role of amniotic fluid homocysteine level and of fetal 5,10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects. Am J Med Genet 2000; 90(12)6
  • Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta 1999; 20: 519–529
  • Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997; 34: 525–526
  • Wang J, Trudinger BJ, Duarte N, Wilcken DE, Wang XL. Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia. BJOG 2000; 107: 935–938
  • Heydrick SJ, Weiss N, Thomas SR, et al. L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells. Free Radic Biol Med 2004; 36: 632–640
  • Dayal S, Brown KL, Weydert CJ, et al. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002; 22: 1996–2000
  • Weiss N, Zhang Y, Heydrick S, Bierl C, Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. PNAS 2001; 98: 12503–12508
  • Upchurch GR, Welch GN, Fabian AJ, et al. Homocyst(e)ine decreases bioavaliable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272: 17012–17017
  • Outinen PA, Sood SK, Pfeifer SI, et al. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 1999; 94: 959–967
  • Beutler E. Red cell metabolism3rd ed. Grune and Stratton, Orlando 1984
  • Tapiero H, Townsend DM, Tew KD. The antioxidant role of selenium and selenocompounds. Biomed Pharmacother 2003; 57: 134–144
  • Holben DH, Smith AM. The diverse role of selenium within selenoproteins: A review. J Am Diet Assoc 1999; 99: 836–843
  • Takebe G, Yarimizu J, Saito Y, et al. A comperative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein. P J Biol Chem 2002; 277: 41254–41258
  • Kelner MJ, Bagnell RD, Montoya MA, Lanham KA. Structural organization of the human gastrointestinal glutathione peroxidase (GPX2) promoter and 3′-nontranscribed region: Transcriptional response to exogenous redox agents. Gene 2000; 248: 109–116
  • Haan JB, Bladier C, Griffiths P, et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stres-inducing agents paraquat and hydrogen peroxide. J Biol Chem 1998; 273: 22528–22536
  • Tan M, Li S, Swaroop M, Guan K, Oberley LW, Sun Y. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 1999; 274: 12061–12066
  • Chu FF, Doroshow JH, Esworthy RS. Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-GI. J Biol Chem 1993; 268: 2571–2576
  • Maddipati KR, Marnett LJ. Characterization of the major hydroperoxide-reducing activity of human plasma. J Biol Chem 1987; 262: 17398–17403
  • Puglisi R, Tramer F, Carlomagno G, et al. PHGPx in spermatogenesis: How many functions?. Contraception 2005; 72: 291–293
  • Hall L, Williams K, Perry ACF, Frayne J, Jury JA. The majority of human glutathione peroxidase type 5 (GPX5) transcripts are incorrectly spliced: Implications for the role of GPX5 in the male reproductive tract. Biochem J 1998; 333: 5–9
  • Kryukov GV, Castellano S, Novoselov SV, et al. Characterization of mammalian selenoproteomes. Science 2003; 300: 1439–1443
  • Yu H, Liu J, Liu X, Zang T, Luo G, Shen J. Kinetic studies on the glutathione peroxidase activity of selenium-containing glutathione transferase. Comp Biochem Physiol 2005; 141: 382–389
  • Flohé L. The selenoprotein glutathione peroxidase. Coenzymes and cofactors, G Dolphin, R Poulson, O Avramovic. John Wiley and Sons, New York 1989; vol. 3.: 644–731

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.